Based on 33 analysts giving stock ratings to Boston Scientific Corp in the past month.
In the current month, BSX has received 15 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the last month is 56.001.
Based on analysts' estimates, BSX EPS is projected to reach 0.775 in FY2026Q4, following reported EPS of 0.402 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.40, while Boston Scientific CorpBSX's earnings per share (EPS) for the previous quarter was USD 0.62. EPS for the next quarter is expected at USD 0.78.